A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study.

Exp Ther Med · 2020 · PMC7027142 · PMID 32104228

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

a trend towards significanceP=0.051so close (0.05 < p ≤ 0.1)

Score values did not differ across the dcSSc and lcSSc groups, with only a trend towards significance for HAQ-DI (P=0.051).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.